Sana Biotechnology, Inc.

Jacob Rubens was supposed to be paying attention in his chemistry lecture. Instead, flipping through Rolling Stone, he stumbled upon an interview that would alter the trajectory of his life. “I was re

Two and a half months after its first US Food and Drug Administration approval for Incyte Corp.-partnered Niktimvo (axatilimab-csfr) in chronic graft-versus-host disease (GVHD), Syndax Pharmaceuticals

Pfizer is progressing its 10-program partnership with Flagship Pioneering , opting to explore new targets in cardiovascular and renal disease with Flagship-founded somatic genomics company Quotient.

Biomedtracker’s latest report on biopharmaceutical company fundraising shows a 25.1% decline in year-over-year dollars raised, from $17.5bn in the fourth quarter of 2022 to $13.1bn in Q4 of 2023. Foll